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Polar cellDuring Drosophila oogenesis, the somatic follicle cells form an epithelial layer surrounding the germline cells
to form egg chambers. In this process, follicle cell precursors are speciﬁed into polar cells, stalk cells, and
main-body follicle cells. Proper speciﬁcation of these three cell types ensures correct egg chamber formation
and polarization of the anterior–posterior axis of the germline cells. Multiple signaling cascades coordinate to
control the follicle cell fate determination, including Notch, JAK/STAT, and Hedgehog signaling pathways.
Here, we show that the Hippo pathway also participates in polar cell speciﬁcation. Over-activation of yorkie
(yki) leads to egg chamber fusion, possibly through attenuation of polar cell speciﬁcation. Loss-of-function
experiments using RNAi knockdown or generation of mutant clones by mitotic recombination demonstrates
that reduction of yki expression promotes polar cell formation in a cell-autonomous manner. Consistently,
polar cells mutant for hippo (hpo) or warts (wts) are not properly speciﬁed, leading to egg chamber fusion.
Furthermore, Notch activity is increased in yki mutant cells and reduction of Notch activity suppresses polar
cell formation in ykimutant clones. These results demonstrate that yki represses polar cell fate through Notch
signaling. Collectively, our data reveal that the Hippo pathway controls polar cell speciﬁcation. Through
repressing Notch activity, Yki serves as a key repressor in specifying polar cells during Drosophila oogenesis.ces and Institute of Genome
iwan. Fax: +886 2 2820 2449.
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Adult tissue homeostasis is often maintained by stem cells, which
continue to provide new cells in response to cell loss due to either
injury or environmental factors (Morrison and Spradling, 2008). Stem
cells are a group of cells capable of self-renewal and producing
daughter cells that have the potential to differentiate into speciﬁc cell
lineages. These cells are regulated by both intrinsic factors and
extrinsic signals from the surrounding microenvironment, known as
niche. Premature differentiation or defective cell division of stem cells
may deplete the stem cell pool and result in tissue atrophy, whereas
excessive proliferation or attenuation of differentiation may lead to
tumorigenesis. Thus, it is critical to investigate the molecular
mechanisms underlying the stem cell regulation.
To dissect signaling pathways that control stem cell properties, such
as cell fate speciﬁcation, Drosophila oogenesis provides a favorable in
vivomodel (Fig. 1A). The Drosophila ovary contains germline stem cells
(GSCs) and two types of somatic stemcells: follicle stemcells (FSCs) and
escort stem cells (Dobens and Raftery, 2000; Horne-Badovinac andBilder, 2005).GSCs andFSCs reside in the germarium, a structure located
at the anterior tip of the ovary (Fuller and Spradling, 2007; Kirilly and
Xie, 2007). Each germarium generally contains two to three GSCs that
continue to divide and give rise to cystoblasts, which then divide four
times synchronously with incomplete cytokinesis to form 16-cell
germline cysts. As germline cysts move posteriorly, they are wrapped
by follicle cells derived from the FSCs and budoff from the germarium to
form individual egg chambers. Two FSCs are located on the opposite
sides in the halfway point of the germarium (Margolis and Spradling,
1995; Nystul and Spradling, 2010). Each FSC divides and gives rise to
twodaughter cells: one daughter cell retains its stemcell properties and
stays in the niche, while the other daughter cell proliferates and
generates multiple follicle cell precursors. These follicle cell precursors
differentiate into three types of follicle cells: main-body follicle cells,
polar cells, and stalk cells. Polar cells are pairs of specialized follicle cells
located at each pole of the egg chamber, whereas ﬁve to eight stalk cells
separate adjacent egg chambers. Main-body follicle cells continue to
proliferate and form an epithelial cell layer surrounding the egg
chamber. Proper speciﬁcation of these three types of cells allows correct
egg chamber formation (Horne-Badovinac and Bilder, 2005).
Different follicular cell types are speciﬁed by coordination of
multiple signaling pathways. In the germarium or stage 1–2 egg
chambers, germline cells secrete Delta (Dl), which activates Notch
Fig. 1. Knockdown of yki increases polar cell numbers. (A) A diagram of the anterior portion of a Drosophila ovariole, including the germarium and early stage egg chambers. The
germarium is divided into four regions. In region 1, germline stem cells (purple) divide and generate cystoblasts, which undergo four times of cell division with incomplete
cytokinesis to form 16-cell cysts. Two follicle stem cells (FSCs, orange) are located at the border of regions 2a and 2b. When a cyst has reached region 2b, follicle cell precursors
(yellow) produced by FSCs migrate between successive egg chambers and begin to intercalate, causing the region 3 egg chamber to be separated from the germarium. These follicle
cell precursors are then speciﬁed into polar cells (red), main-body follicle cells (gray), and stalk cells (green). Follicle cell precursors and polar cells were labeled by anti-FasIII
antibody in (B–F). Cell nuclei were stained by DAPI in (B–F). (B, C) The expression pattern of Yki in heterozygous FRT42D ykiB5 ovaries. Yki was not detected in a homozygous yki
mutant cell (GFP-negative) circled by yellow dashed lines. Follicle cell precursors and polar cells with a low level of Yki nuclear distribution are indicated by yellow arrows and
yellow arrowheads, respectively. (D) c306-Gal4 was used to drive GFP expression from a UAS-GFP transgene. GFP was expressed at high level in all follicle cell precursors in the
germarium (yellow bracket) and polar cells (yellow arrowheads), but lower in the main-body follicle surrounding polar cells. (E) Expression of yki-S111A, S168A, S250Awith c306-
Gal4 driver. Polar cells and stalk cells were not properly formed between egg chambers (white bracket) and egg chambers fused together. (F) Knockdown of yki in follicle cell
precursors by a RNAi line P{KK109756}v104523 using c306-Gal4 driver. Numbers of FasIII-positive cells were increased (white brackets). Numbers of main-body follicle cells were
decreased and egg chambers were not fully covered by main-body follicle cells (white dashed lines). Length of scale bars is 10 μm for all panels.
371H.-J. Chen et al. / Developmental Biology 357 (2011) 370–379signaling in some follicle cell precursors and speciﬁes these cells into
polar cells. Mutation of Dl in the germline cells or mutation of Notch in
the follicle cell precursors results in loss of polar cells, leading to egg
chamber fusion (Lopez-Schier and St Johnston, 2001; Torres et al.,
2003). Similarly, follicle cell precursors mutant for fringe (fng), a
positive regulator of Notch signaling, also fail to differentiate intopolar cells (Grammont and Irvine, 2001). Over-expression of an active
form of Notch driven by either c306-Gal4 (see below) or heatshock-
Gal4 increases numbers of polar cells and stalk cells (Larkin et al.,
1996; Shyu et al., 2009). Once polar cells are speciﬁed, they secrete Dl
and Unpaired (Upd), the JAK/STAT pathway ligand, that subsequently
induce adjacent follicle cell precursors to differentiate into stalk cells
372 H.-J. Chen et al. / Developmental Biology 357 (2011) 370–379(Assa-Kunik et al., 2007; McGregor et al., 2002). Thus, the speciﬁca-
tion of stalk cells requires signals released from the polar cells. Besides
Notch, the Hedgehog (Hh) signaling also regulates polar cell
formation. Over-activation of the Hh pathway delays follicle cell
differentiation and causes an increase in the number of polar cells
(Forbes et al., 1996; Tworoger et al., 1999; Zhang and Kalderon, 2000).
This ectopic polar cell formation is caused by an inhibition of Eyes
absent (Eya), a tyrosine phosphatase and transcriptional co-activator
that represses polar cell fate (Bai and Montell, 2002). Furthermore, a
downstream effector of the Notch signaling Extra macrochaetae
(Emc) also regulates follicle cell fate by repressing eya expression
(Adam and Montell, 2004). While interplay among these signaling
pathways speciﬁes different types of follicle cells, other signaling
pathways participating in this process remain to be elucidated.
The Hippo pathway is recently identiﬁed to play important roles in
cell proliferation and organ size control (Camargo et al., 2007; Halder
and Johnson, 2011; Harvey and Tapon, 2007; Lian et al., 2010; Lu et al.,
2010; Oh and Irvine, 2010; Pan, 2010; Saucedo and Edgar, 2007; Song
et al., 2010; Zhang et al., 2009, 2010). The core components of the
Hippo pathway are Hippo (Hpo),Warts (Wts), Salvador (Sav),Mob as a
tumor suppressor (Mats), and Yorkie (Yki). Hpo is an Ste20-like kinase
that forms a complex with the adaptor protein Sav and phosphorylates
Wts, a nuclear Dbf2-related (NDR) family kinase (Harvey et al., 2003;
Justice et al., 1995; Pantalacci et al., 2003; Udan et al., 2003; Watson,
1995;Wu et al., 2003). In associationwith the adapter proteinMats (Lai
et al., 2005), Wts phosphorylates Yki, a transcriptional co-activator
(Huang et al., 2005;Wei et al., 2007). Phosphorylated Yki interacts with
14-3-3 phosphopeptide binding protein, resulting in a retention of Yki
in the cytoplasm and repression of its transcriptional activity (Dong
et al., 2007; Huang et al., 2005; Oh and Irvine, 2008; Ren et al., 2010b).
When Yki is not phosphorylated, it is localized to the nucleus and
interacts with transcription factors such as Scalloped (Sd) to activate
target gene expression. Most identiﬁed target genes of Yki, such as
cyclin E, Myc, diap, and bantam, promote cell proliferation or cell
survival (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008; Zhao
et al., 2008; Ziosi et al., 2010). For the upstream regulators, Merlin
(Mer) and Expanded (Ex), two FERM domain-containing family
proteins, as well as the WW and C2 domain-containing protein Kibra,
interact with the Hippo kinase cascade and activate Wts (Baumgartner
et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006; McCartney
et al., 2000; Yu et al., 2010).Mediators of the planar cell polarity, such as
the atypical cadherin Fat (Ft) and the unconventional myosin Dachs,
also inﬂuence the Hippo pathway (Bennett andHarvey, 2006; Cho et al.,
2006; Silva et al., 2006; Tyler and Baker, 2007; Willecke et al., 2006,
2008; Zecca and Struhl, 2010). All components of the Hippo pathway
are highly conserved from Drosophila to mammals, suggesting that this
pathway is essential for cellular functions in a variety of organisms
(Badouel et al., 2009; Chan et al., 2010; Durrheim and Leggat, 1999;
Harvey and Tapon, 2007; Pan, 2010; Zeng and Hong, 2008). Recently,
the Hippo pathway has also been shown to control proliferation and
differentiation potential of stem cells. InDrosophila intestinal stem cells,
the Hippo pathway is required for stem cell division in response to
tissue damage through the JAK/STAT and EGFR signaling pathways
(Karpowicz et al., 2010; Ren et al., 2010a; Shaw et al., 2010; Staley and
Irvine, 2010). Consistent with the ﬁndings in Drosophila, the Hippo
pathway controls cell proliferation and differentiation of liver progen-
itor/stem cells in mice (Camargo et al., 2007; Lu et al., 2010; Song et al.,
2010; Zhang et al., 2010). Furthermore, themammalian homolog of Yki,
YAP, is inactivated during embryonic stem (ES) cell differentiation.
Knockdown of YAP leads to a loss of ES cell pluripotency, while over-
expression of YAP prevents ES cell differentiation (Lian et al., 2010).
While the roles of the Hippo pathway in regulating stem cell properties
are emerging, whether the Hippo pathway controls other developmen-
tal processes remains to be explored.
Here, we report that the Hippo pathway participates in polar cell
fate determination in the Drosophila ovary. Yki is excluded from thenuclei of some follicle cell precursors and polar cells, suggesting that
Yki activity is suppressed during polar cell speciﬁcation. Over-
activation of Yki leads to egg chamber fusion and defective polar
cell and stalk cell formation. By using both RNAi and clonal analysis
approaches, we ﬁnd that follicle cells with reduced or lacking yki
expression differentiate into polar cells. Consistently, polar cells with
either hpo or wts mutations are not speciﬁed properly. Furthermore,
Yki suppresses polar cell fate through inhibiting Notch activity. Our
results have revealed a novel role of the Hippo pathway in cell fate
speciﬁcation and increase understanding of how signaling pathways
interplay to determine cell fate.
Materials and methods
Fly stocks
The ﬂy stocks for RNAi and Yki immunostaining experiments were
(Dietzl et al., 2007): FRT42D ykiB5,w+/CyO, hs-ﬂp;FRT42D ubiGFP/CyO,
P{GawB}c306, UAS-GFP, w1118;P{GD11187}v40497/TM3, w1118;P
{KK109756}v104523. The ﬂy stocks: y1w⁎; P{UAS-yki.S168A.GFP}10-
7-Y, y1w⁎; P{UAS-yki.GFP}4-12-1 w⁎; P{UAS-yki.S111A.S168A.S250A.
V5}attP2were for over-expression of yki. Fly lines used clonal analyses
were: hs-ﬂp;FRT42D ubiGFP/CyO, ey-ﬂp;FRT42D, FRT42D ykiB5,w+/CyO,
FRT42D hpo42–47/CyO,w+, hs-ﬂp;FRT82B ubiGFP/TM3,Sb, ey-ﬂp;FRT82B,
FRT82B wtsx1/TM3,Sb, FRT82B wts3–17/TM3,Sb, FRT42D;neu P[lac ry]
A101/TM3,Sb, FRT42D ykiB5,w+/CyO;neu P[lac ry] A101/TM3,Sb, FRT42D
hpo42–47/CyO,w+;neu P[lac ry] A101/TM3,Sb, yd2w1118P{ey-FLP.N}2;P
{neoFRT}42D hpoKC202/CyO,P{GAL4-Kr.C}DC3, P{UAS-GFP.S65T}DC7,
N55e11FRT101/FM6b;FRT42D, N55e11FRT101/FM6b;FRT42D ykiB5,w+/
CyO, FRT42D; Gbe-Su(H)-lacZ, FRT42D ykiB5,w+/CyO;Gbe-Su(H)-lacZ,
w*;dGC13P{neoFRT}40A/CyO, P{ActGFP}JMR1, y1w*Mer4P{neoFRT}19A/
FM7i, FRTP{ActGFP}JMR3, FRT82B sav3/TM6b, FRT82B matse235/TM6b,
ft8FRT40A/Tb, exe1FRT40A/CyO,Tb, FRT82B kibra001/TM6b, lacZ FRT40A,
FRT19A, sdΔBFRT19A/FM7, ubiGFP FRT19A;hs-ﬂp,Sb/TM6b. ptc-lacZ/CyO;
FRT82B wts3–17/TM3,Sb.
The FRT82B wts3–17/TM3,Sb ﬂy line, was generated by standard
meiotic recombination with st1in1kniri–1ppwts3–17/TM3 and ey-ﬂp;
FRT82B (Xu and Rubin, 1993).
Over-expression of yki and RNAi experiments
Flies were cultured at 18 °C before eclosion. Newly eclosed adult
ﬂies were collected and grown at 30 °C for 5–6 days before dissection.
Generation of mitotic clones
The FLP/FRP site-speciﬁc recombination system was used to
generate mutant clones with a heatshock promoter (Xu and Rubin,
1993). Newly eclosed ﬂies were collected for two consecutive days,
then heatshocked at 37 °C four times over the next two days. On the
ﬁrst day they were heatshocked twice for 30 min each with a four-
hour interval between heatshocks. On the second day they were
heatshocked once for 30 min then once for 1 h. All ﬂies were
incubated at 25 °C for six days before dissection.
Antibodies
The following antibodies were used: mouse anti-Fasciclin III [7G10,
Developmental Studies Hybridoma Bank (DSHB)], mouse anti-β-
Galactosidase (40-1A, DSHB), mouse anti-Notch intracellular domain
(C17.9C6, DSHB), mouse anti-Eya (eya10H6, DSHB), rabbit anti-GFP
(Invitrogen, Carlsbad, CA, USA), rabbit anti-β-Galactosidase (Millipore,
Billerica, MA, USA), Dylight-488 goat anti-rabbit IgG(H+L), Dylight-
549 goat anti-mouse IgG(H+L) (Jackson ImmunoResearch Laborato-
ries, Inc.,WestGrove, PA, USA), andAlexa Fluor 633 goat anti-mouse IgG
373H.-J. Chen et al. / Developmental Biology 357 (2011) 370–379(H+L) (Invitrogen, Carlsbad, CA, USA), anti-Yki (provided by Dr.
Kenneth D. Irvine, Rutgers University).
Immunostaining and ﬂuorescence microscopy
Ovaries were dissected at six days after heatshock in phosphate-
buffered saline (PBS) and ﬁxed in 4% paraformaldehyde (PFA) in PBS.
After ﬁxation, ovaries were rinsed with PBT (1XPBS, and 0.2% Triton
X-100) followed by incubation in the blocking solution PBTB (1XPBS,
0.5% Triton X-100, 5% goat serum, 2.5 mg/ml BSA, and 0.05% Sodium
azide). Ovaries were then incubated with the primary antibodies
overnight at 4 °C, washed with PBT, and followed by secondary
antibody staining. Ovaries were further stained with DAPI in PBT
(1 μg/ml, Sigma) prior to mounting with mounting solution [85%
glycerol, 1XPBS, 3% propyl gallate (Sigma), and ProLong® Gold
Antifade reagents (Invitrogen, Carlsbad, CA, USA)]. Images were
taken by confocal microscopies including Leica TCS SP2 (Leica
Microsystems GmbH, Germany), Olympus FV1000 (Olympus Corpo-
ration, Japan), and Zeiss LSM700 (Carl Zeiss AG, Germany). The
images were processed in Adobe Photoshop CS3 (San Jose, CA, USA).
Signal intensities for β-Galactosidase of A101 were quantiﬁed using
ImageJ (National Institute of Health, Bethesda, Maryland, USA).
Results
To explore roles of the Hippo pathway during Drosophila
oogenesis, we examined the expression pattern and cellular localiza-
tion of Yki. First, we showed the speciﬁcity of the Yki antibody in the
Drosophila ovary by staining of yki mutant clones. These yki mutant
clones were generated by mitotic recombination with a yki amorph,
ykiB5 (Xu and Rubin, 1993). The absence of anti-Yki staining in yki
mutant follicle cell clones demonstrated that the antibody speciﬁcally
recognizes Yki (Fig. 1B). Yki was not detected in germline cells, which
is consistent with previous ﬁndings that the Hippo pathway is
dispensable in germline cells (Shcherbata et al., 2007; Sun et al.,
2008). On the other hand, Yki was detected in most follicle cells (Figs.
1B, C). To distinguish different follicle cell types, we stained the
ovaries with an antibody against Fasciclin III (FasIII), which labels
follicle cell precursors in the germarium and polar cells in developing
egg chambers (Figs. 1B,C) (Ruohola et al., 1991). The immunostaining
results showed that Yki is expressed in follicle cell precursors, main-
body follicle cells, and polar cells (Figs. 1B, C). Interestingly, despite its
function as transcriptional co-activator, subcellular localization of Yki
is restricted to the cytoplasm in polar cells in stage 2–3 egg chambers
(Figs. 1B, C). This restriction is also observed in some follicle cell
precursors located at the boundary between germarium regions 2b
and 3, where polar cells are presumably speciﬁed (Fig. 1C) (Nystul
and Spradling, 2010). Since nuclear localization is necessary for its
transcriptional activity, exclusion of Yki from the nucleus suggests
that Yki activity prevents follicle cell precursors to differentiate into
polar cells.
To test this hypothesis, we ﬁrst over-expressed wild-type yki, yki-
S168A, and yki-S111A, S168A, S250A in follicle cell precursors and
examined polar cell formation. Ser residues at positions 111, 168, and
250 of Yki are phosphorylated by Wts and the phosphorylation
prevents its nuclear localization. The Ser168 to Ala mutation of Yki
reduces, but not eliminates the regulation by Wts. The Ser 111, 168,
250 to Ala mutation of Yki stays in the nucleus to activate expression
of downstream targets (Oh and Irvine, 2008, 2009). Expression of
wild-type or mutant yki was driven with a c306-Gal4 line (Manseau
et al., 1997). The c306-Gal4 line was ﬁrst crossed with a UAS-GFP line
and the result demonstrated that c306-Gal4 is expressed in all follicle
cell precursors in the germarium (Fig. 1D). In egg chambers from
stage 3 onward, GFP was detected at a high level in polar cells and
lower in the main-body follicle cells surrounding polar cells (Fig. 1D).
Over-expression of the constitutively active yki-S111A, S168A, S250Ain follicle cell precursors resulted in egg chamber fusion (Fig. 1E and
Fig. S1C in the Supplementary Data; 91.7%, n=192), possibly due to
the loss of polar cells and stalk cells. Over-expression of yki or yki-
S168A did not affect polar cell differentiation and the exogenous Yki
remained in the cytoplasm (Fig. S1A, B; nN20), suggesting that Yki
localization and activity is regulated in the polar cells. Knockdown of
yki in follicle cell precursors with c306-Gal4 and an RNAi line P
{KK109756}v104523 led to an increase in the number of FasIII-
expressing cells in stage 2–5 egg chambers (Fig. 1F; nN20). These
excessive FasIII-positive cells were morphologically similar to polar
cells in stage 6 egg chambers (Fig. S2A). The same phenotypes were
observed in another RNAi line P{GD11187}v40497 (Fig. S2B and data
not shown), suggesting that the phenotypes were not resulted from
off-target effects of RNAi. In addition to the extra polar cells, many egg
chambers were not fully encapsulated by main-body follicle cells
(Fig. 1F and Fig. S2). These results suggested that most yki-knocked
down follicle cell precursors differentiated into polar cells at the
expense of the follicle cell precursors that were supposed to
differentiate into main-body follicle cells.
To further explore whether reduction of Yki is sufﬁcient to specify
polar cells, we generated ykiB5 mutant clones. FRT42D clones were
generated as a control. In the control group, GFP-negative clones
contained both polar cells and main-body follicle cells, indicating that
follicle cell precursors can differentiate into both cell types (Fig. 2A;
nN20). Most ykimutant cells expressed FasIII in the same pattern and
intensity as polar cells even in an egg chamber that already contained
two pairs of polar cells (Fig. 2B; 76.7%, n=43). To conﬁrm if these
ectopic FasIII-positive cells had similar or the same properties as polar
cells, we used an enhancer trap line A101 (neuralized-lacZ), whose
lacZ is expressed exclusively in polar cells (Fig. 2C; n=8) (Bellen et al.,
1989; Lopez-Schier and St Johnston, 2001). In most yki mutant cells,
β-Galactosidase (β-Gal) was detected (Fig. 2D; 95.9%, n=49),
suggesting that these yki mutant cells were indeed polar cells. We
further examined the expression of eya, which should be in the main-
body follicle cells but absence from polar cells (Bai andMontell, 2002).
ykimutant cells showed reduced or absence of Eya (Figs. 2E, F; 34.8%,
n=69). In consistent with the ﬁndings from our RNAi experiments,
these results demonstrated that yki mutant cells differentiated into
polar cells in a cell-autonomous manner.
Because Hpo and Wts are negative regulators of Yki, their effects
on polar cell fate should be opposite to that of Yki. To examine such
effects, we generated mutant clones with loss-of-function allele
hpo42–47 or wts3–17. We speciﬁcally analyzed those pairs of polar cells
with one GFP-negative hpo or wts mutant polar cell and one GFP-
positive control polar cell (Figs. 3A–F). hpo or wts mutant polar cells
expressed less FasIII or A101-β-Gal in comparison with the adjacent
control polar cells (Figs. 3A–F; reduced FasIII staining in hpo: 85.7%,
n=21; reduced A101-β-Gal: 75%, n=20; reduced FasIII staining in
wts: 61.5%, n=13). In A101-lacZ background, the β-Gal staining
intensity in hpo mutant polar cells was reduced to 58% of that in the
adjacent control polar cells (Fig. S3). The same phenotypes were
observed when loss-of-function allele hpoKC202 or wtsX1 was used
(data not shown). In addition, low levels of both the polar cell marker
A101 and the main-body follicle cell marker Eya were detected
simultaneously in hpomutant polar cells (Figs. 3G, H). Together, these
results suggested that polar cell fate in hpo orwtsmutant cells are not
properly speciﬁed.
It has been shown that polar cells are required for the formation of
stalk cells to separate individual egg chambers. Without stalk cells,
egg chambers are fused (Assa-Kunik et al., 2007). In the ovarioles
where most of the follicle cells were mutant for hpo or wts, we
observed fused egg chambers (Fig. 4; hpo and wts: nN10). hpo-
deﬁcient polar cells expressing both themain-body follicle cell marker
Eya and the polar cell marker A101-β-Gal were found near the middle
of the fused egg chamber (Fig. 4A). Some fused egg chambers did not
contain any A101-β-Gal- or FasIII-positive or Eya-negative polar cells
Fig. 2. ykimutant cells differentiate into polar cells in a cell-autonomous manner. GFP-negative mitotic clones were generated in FRT42D (A, C, E) or FRT42D ykiB5 (B, D, F). Dissected
ovaries were immunostained with anti-FasIII (A, B), anti-β-Gal (A101 β-Gal from the A101-lacZ line; C, D), or anti-Eya antibodies (E, F). Polar cells express FasIII and A101 β-Gal,
whereas main-body follicle cells express Eya. Stage 4–6 egg chambers were selected and orientated as anterior toward left. (A) FRT42D control cells (GFP-negative) differentiated
into either FasIII-positive polar cells (yellow arrowheads) or FasIII-negative main-body follicle cells (yellow dashed lines). (B) yki mutant cells differentiated into ectopic FasIII-
positive cells (yellow arrowheads) with a similar morphology of polar cells (white arrowheads). (C) FRT42D control cells differentiated into either A101-positive polar cells (yellow
arrowheads) or A101-negative main-body follicle cells. (D) yki mutant cells differentiated into A101-positive cells (yellow arrowheads) with a similar morphology of polar cells
(white arrowheads). (E) FRT42D control cells differentiated into Eya-positive main-body follicle cells or Eya-negative polar cells (yellow arrowheads). (F) Similar to normal polar
cells (white arrowheads), yki mutant cells (yellow arrowheads) did not express Eya. Length of scale bars is 10 μm for all panels.
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them (Figs. 4B–E). These results further suggest that Hpo or Wts is
required for polar cell speciﬁcation, possibly through inactivation of
Yki as the canonical Hippo pathway. Indeed, Yki appeared to
distribute throughout the nucleus and cytoplasm in wts mutant
polar cells (Fig. S4), supporting that Wts affects polar cell formation
via cytoplasmic retention of Yki by phosphorylation. We further
tested if other components of the Hippo pathway inﬂuence polar cell
speciﬁcation. For the upstream components ex, Mer, kibra, fat, and
dachs, only kibra mutant polar cells expressed less FasIII (Fig. S5C;
n=5), while polar cells mutant for ex, Mer, fat, or dachs were
indistinguishable from control polar cells (Fig. S6B–E; nN10). Sd is a
transcription factor interacting with Yki (Wu et al., 2008; Zhang et al.,
2008). Cells mutant for sd expressed FasIII (Fig. S5B; 94.6%, n=37),suggesting that these cells differentiated into ectopic polar cells,
which is similar to yki mutant cells. Interestingly, while the mats
mutant cells failed differentiate into polar cells and led to egg chamber
fusion (Fig. S5D; n=26), mutation of sav did not affect polar cell
speciﬁcation (Fig. S6F; nN20).
Loss of Notch activity in the follicle cells results in no polar cells
and egg chamber fusion (Grammont and Irvine, 2001; Lopez-Schier
and St Johnston, 2001), which is similar to the phenotypes of hpo or
wts mutants. Over-activation of Notch, on the other hand, increases
polar cell numbers, which is similar to the phenotypes of yki mutants
(Assa-Kunik et al., 2007; Larkin et al., 1996; Shyu et al., 2009).
Therefore, we hypothesized that the Hippo pathway regulates polar
cell fate through Notch signaling. To test if the Hippo pathway affects
Notch signaling, we generated FRT42D control clones or ykiB5 mutant
Fig. 3. Polar cells mutant for hpo or wts do not differentiate properly. Dissected ovaries were immunostained with anti-FasIII (A, B, E, F), anti-β-Gal (A101 β-Gal; C, D, G, H), or anti-
Eya antibodies (G, H). (A, C) FRT42D control cells (GFP-negative) differentiated into FasIII- or A101-positive polar cells at both ends of egg chambers. For each pair of polar cells, levels
of FasIII or β-Gal were approximately equal between GFP-positive cells (white arrowheads) and GFP-negative cells (yellow arrowheads). (B, D) The level of FasIII or A101 β-Gal in
hpo42–47mutant polar cell (GFP-negative, yellow arrowheads) was decreased in comparison with that in the neighboring control polar cells (GFP-positive, white arrowheads). (E) In
FRT82B control group, levels of FasIII were approximately equal between GFP-positive cells (white arrowheads) and GFP-negative cells (yellow arrowheads). (F) The FasIII level in
wts3–17mutant polar cell (yellow arrowheads) was decreased in comparison with that in the neighboring GFP-positive control polar cells (white arrowheads). (G) In FRT42D control
cells, A101 β-Gal was detected exclusively in polar cells (white arrowheads) and Eya was detected in main-body follicle cells. (H) In hpo42-47mutant polar cells (yellow arrowheads),
the A101 β-Gal was reduced and Eya was induced ectopically in comparison with that of the control GFP-positive polar cells (white arrowheads). The other polar cell at the posterior
end was not located at the same focal plane. Length of scale bars is 10 μm for all panels.
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Fig. 4. Egg chamber fusion in hpo or wtsmutant ovarioles. Dissected ovaries were immunostained with anti-FasIII (C, D), anti-β-Gal (A101 β-Gal; A, B), or anti-Eya antibodies (A, B,
E). (A) A fused egg chamber with hpo42–47 mutant cells. A pair of GFP-negative hpo mutant cells expressing low levels of both Eya and A101 β-Gal was located near the junction
between two egg chambers (yellow arrowheads). (B, C) Various degrees of fused egg chambers resulted from hpo42–47 mutation. No A101 β-Gal- or FasIII-positive polar cells were
observed between these fused egg chambers. (D, E) Fused egg chambers caused bywts3–17mutation. No FasIII-positive or Eya-negative polar cells were observed between these egg
chambers. Length of scale bars is 10 μm for all panels.
376 H.-J. Chen et al. / Developmental Biology 357 (2011) 370–379clones in a Notch activity reporter line, Gbe-Su(H) lacZ. The lacZ
expression was increased in polar cells and yki mutant follicle cells
(Figs. 5A, B; FRT42D clones: 13.5% contained cells with increased lacZ
expression levels, n=52; yki: 68.5%, n=54), indicating that the Notch
pathway was activated. This result suggested that yki represses Notch
activity. If yki suppresses polar cell fate by inhibiting Notch activity,
reduction of Notch in yki mutant cells should attenuate ectopic polar
cell formation resulted from yki mutation. ykiB5 mutant clones were
generated in either a wild-type Notch background or a heterozygous
background for a Notch amorph, N55e11. While yki mutant cells
differentiated into polar cells expressing high levels of FasIII in the
wild-type Notch background (Fig. 5C; n=7), yki mutant cells in the
reduced Notch background expressed less FasIII (Fig. 5D; 88.5% of the
clones with reduced FasIII levels, n=26). These results support our
hypothesis that the Hippo pathway acts upstream of Notch in polar
cell speciﬁcation (Fig. 5E).
Discussion
In this study, we identify a novel role of the Hippo pathway: cell
fate speciﬁcation during Drosophila oogenesis. yki mutant cells
differentiate into polar cells in a cell-autonomous manner; hpo or
wts mutant cells do not differentiate into polar cells properly. Our
results demonstrate that hpo/wts and yki play opposite roles in polar
cell formation, and yki represses polar cell fate. Furthermore, yki
inhibits Notch activity, and reduction of Notch activity attenuates the
polar cell speciﬁcation phenotype in ykimutant cells. Taken together,
we propose that Hpo andWts regulate the activity of Yki in the follicle
cell precursors. Inactivation of Yki leads to up-regulation of Notch
activity, thereby specifying polar cell fate. On the other hand, increaseof Yki activity promotes follicle cell precursors to differentiate into
main-body follicle cells (Fig. 5E).
In addition to hpo, wts, and yki, we have examined effects of other
Hippo pathway components on polar cell speciﬁcation during early
oogenesis (Figs. S5, 6). Most upstream components, including ex,Mer,
fat, and dachs, do not affect polar cell determination individually. A
possibility is that they act redundantly to activate the Hippo pathway
(Hamaratoglu et al., 2006). Therefore, mutation of individual
upstream regulators is insufﬁcient to inhibit the Hippo pathway
activity thoroughly. Alternatively, the Hippo pathway may be
inﬂuenced under different signalings in the follicle cells during early
oogenesis.
Under the control of both extrinsic and intrinsic signals, follicle cell
precursors differentiate into polar cells, main-body follicle cells, or
stalk cells. Polar cells exist from cell cycle soon after cell fate
speciﬁcation (Nystul and Spradling, 2010). Mis-expression of String,
a Drosophila Cdc25-type phosphatase, with c306-Gal4 driver in polar
cells triggers polar cell proliferation and increases polar cell numbers
(Shyu et al., 2009). Therefore, an increase of polar cells can be resulted
from either proliferation of polar cells or fate change of other cells that
are not supposed to differentiate into polar cells. When we knocked
down yki in follicle cell precursors with c306-Gal4, we observed an
increase of FasIII-positive cells, presumably polar cells (Figs. 1F, S2).
Since c306-Gal4 is expressed in almost all follicle cell precursors
(Fig. 1D), it is likely that yki reduction promotes most of them to
differentiate into polar cells. Because few follicle cell precursors are
left to differentiate into main-body follicle cells, egg chambers are not
thoroughly enwrapped. It is less likely that knockdown of yki
promotes polar cell proliferation because yki mutant clones usually
contain only one to two polar cells (Figs. 2B, D, F), suggesting that
Fig. 5. Notch acts downstream of yki in polar cell speciﬁcation. (A) lacZ expression of a Notch activity reporter line, Gbe-Su(H)-lacZ, was increased in putative polar cells (white
arrowheads) but not in the GFP-negative FRT42D control cells (yellow dashed lines). (B) lacZ expression of a Notch activity reporter line was increased in ykiB5 mutant cells (yellow
arrowheads). (D) Under a wild-type Notch background, ykiB5 mutant cells differentiated into FasIII-positive polar cells (yellow arrowhead). (D) Under the Notch55e11 heterozygous
background, FasIII levels in ykiB5 mutant cells (yellow dashed lines) were dramatically less than that of the control polar cells (white arrowheads) or yki mutant cells in (C). (E) A
model illustrates how the Hippo pathway regulates polar cell fate. Reduction of Yki activity leads to activation of Notch, which confers polar cell fate in follicle cell precursors.
377H.-J. Chen et al. / Developmental Biology 357 (2011) 370–379reduction of yki specify polar cell fate and these cells withdraw from
cell cycle immediately.
Previous studies have shown interactions between the Hippo
pathway and Notch signaling in Drosophila. Hippo pathway controls
endocytosis of Notch. Mer and Ex are two upstream components that
promote activation and phosphorylation of Hpo. In Mer ex double
mutant cells on the wing or eye imaginal discs, Notch levels are up-
regulated at the plasma membrane due to a defect in receptor
clearance from the cell surface. A slight increase in Notch activity is
observed in these Mer ex double mutant cells (Maitra et al., 2006).
Disruption of hpo or sav also leads to abnormal accumulation and
distribution of Notch in the posterior follicle cells in stage 7–10 egg
chambers (Yu et al., 2008). However, Notch activity is attenuated in
these hpo or sav mutant cells (Meignin et al., 2007; Polesello andTapon, 2007; Yu et al., 2008). Despite the discrepancy in different
tissues, most ﬁndings indicate that the Hippo pathway regulates
Notch signaling through receptor processing or localization. In our
study, we also observed that yki regulates Notch activity as well as a
genetic interaction between yki and Notch in polar cell speciﬁcation
during early oogenesis. However, the expression level and pattern of
Notch are not changed in yki, hpo, or wtsmutant clones in early stage
egg chambers based on immunoﬂuorescence results with an antibody
against the Notch intracellular domain (NICD) (Fig. S7). How the
Hippo pathway controls Notch activity during polar cell speciﬁcation
remains to be investigated.
Besides Notch, the Hh signaling also regulates polar cell formation.
Over-activation of the Hh pathway delays follicle cell differentiation
and causes an increase in the number of polar cells (Forbes et al.,
378 H.-J. Chen et al. / Developmental Biology 357 (2011) 370–3791996; Tworoger et al., 1999; Zhang and Kalderon, 2000). We have
tested if the Hippo pathway affects the Hh signaling by using a ptc-lacZ
reporter line during polar cell speciﬁcation. lacZ expression was not
affected in wts mutant clones during polar cell speciﬁcation in the
germarium region 3 (Fig. S8; nN10), suggesting that the Hh signaling
does not act downstream of the Hippo pathway in polar cell
speciﬁcation. Further experiments are required to examine if the
Hippo pathway interacts with other signaling pathways during polar
cell formation.
Eyes absent (Eya) is a transcriptional co-activator and a protein
tyrosine phosphatase required for the formation and speciﬁcation of
not only the Drosophila eyes but also many other tissues in a variety of
organisms (Jemc and Rebay, 2007). During Drosophila oogenesis, Eya
is a critical repressor of polar cell fate. Eya is present in follicle cell
precursors and main-body follicle cells, but not in polar cells. Loss of
eya induces ectopic polar cells in a cell-autonomous manner, which is
similar to the phenotypes of ykimutant cells (Bai and Montell, 2002).
Furthermore, the Notch pathway acts upstream of eya. Because Eya is
reduced or absent in yki mutant clones and up-regulated in hpo
mutant polar cells (Figs. 2F, 3H, 4E), it is likely that yki functions
upstream of eya and controls eya expression through the Notch
signaling.
In Drosophila, the Hippo pathway components hpo, wts, and sav
have been shown to deﬁne the R8 photoreceptor cell fate (Mikeladze-
Dvali et al., 2005). Here, we ﬁnd that hpo, wts, and yki are critical for
polar cell speciﬁcation during oogenesis. Whether the Hippo pathway
controls cell fate in other tissues in Drosophila or in different
organisms remains to be explored.While most identiﬁed downstream
targets of yki, such as diap, cycE, bantam, dMyc, and expanded, are all
involved in cell cycle regulation or cell survival, it would be important
to identify new yki downstream target genes that participate in cell
fate determination. Our ﬁndings contribute to the understanding of
molecular mechanisms controlling cell fate determination and
provide new insights of the pleiotropic Hippo pathway.
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